Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission-Reference-Cited by-同舟云学术

Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission

Published:2011-10-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pidala Joseph¹,Djulbegovic Benjamin²,Anasetti Claudio¹,Kharfan-Dabaja Mohamed¹,Kumar Ambuj³

Affiliation:

1. Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center; Tampa Florida USA

2. Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida; Professor of Medicine and Oncology, H. Lee Moffitt Cancer Center; USF Health Clinical Research, 12901 Bruce B. Downs Boulevard, MDC02 Tampa Florida USA 33612

3. University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; Tampa Florida USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference45 articles.

1. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group;Attal;Blood,1995

2. Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study;Bernasconi;Leukemia,1992

3. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison;Cornelissen;Blood,2009

4. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission;Witte;Bone Marrow Transplant,1994

5. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXI /ECOG2993;Fielding;Blood,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Pediatric chemotherapy versus allo-HSCT for adolescent and adult Philadelphia chromosome-negative ALL in first complete remission: a meta-analysis;Annals of Hematology;2023-03-22

3. Leucémie aiguë lymphoblastique dans les pays en voie de développement : prise en charge dès l’indication de greffe jusqu’au suivi post-greffe. Recommandations de la SFGM-TC;Bulletin du Cancer;2023-02

4. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2022-12

5. CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission;HemaSphere;2022-10-12